CNMD — Conmed Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMid CapNeutral
- $2.53bn
- $3.53bn
- $1.01bn
- 83
- 26
- 47
- 54
Annual cashflow statement for Conmed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 55.5 | 40.9 | 28.6 | 9.52 | 62.5 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 8.47 | 14.2 | 24.1 | 26.5 | 31.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -16.9 | -44.3 | -23.6 | -29.9 | -55.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 65.6 | 74.7 | 95.1 | 64.5 | 112 |
| Capital Expenditures | -12.8 | -16.5 | -20.1 | -13 | -14.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -16.2 | 0 | -368 | -0.625 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -29.1 | -16.5 | -388 | -13.6 | -14.9 |
| Financing Cash Flow Items | -0.372 | -20.1 | -69.9 | -2.99 | 2.95 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -34.9 | -72.3 | 301 | -52.1 | -102 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.19 | -15.1 | 8.35 | 1.5 | -6.51 |